News page specific

Bypassing Genetic Bottlenecks With the CRISPR-SNP-Chip

Since its invention in 1983, genomics laboratories across the globe have been utilizing the polymerase chain reaction (PCR) to amplify DNA. Since then, few fundamentally new technologies have been invented in this area. In order to “democratize” the field of genomics, Cardea Bio has developed the CRISPR-SNP-Chip, a system that enables the detection of many biomolecules directly, using a minimally processed sample.

We spoke to Cardea Bio's CEO, Michael Heltzen, and Dr. Kiana Aran, chief scientific officer, to find out more about the development of the SNP-Chip and how it has been used in a recent study to detect sickle cell disease and amyotrophic lateral sclerosis (ALS).

Written by Cardea Bio

But I must explain to you how all this mistaken idea of denouncing pleasure and praising pain was born and I will give you a complete account of the system.